Top compounds associated with response to C1orf228


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA CIL55 CTRPv2 pan-cancer AAC -0.019 0.7
mRNA ML320 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.011 0.7
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.012 0.7
mRNA austocystin d CTRPv2 pan-cancer AAC -0.012 0.8
mRNA Irinotecan gCSI pan-cancer AAC 0.018 0.8
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA TAE684 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC 0.013 0.8
Download CSV